These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29022889)

  • 1. ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II).
    De Sousa SMC; Stowasser M; Feng J; Schreiber AW; Wang P; Hahn CN; Gordon RD; Torpy DJ; Scott HS; Gagliardi L
    J Hum Hypertens; 2017 Dec; 31(12):857-859. PubMed ID: 29022889
    [No Abstract]   [Full Text] [Related]  

  • 2. ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.
    Mulatero P; Schiavi F; Williams TA; Monticone S; Barbon G; Opocher G; Fallo F
    J Hum Hypertens; 2016 Jun; 30(6):374-8. PubMed ID: 26446392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GERMLINE DELETION OF ARMC5 IN FAMILIAL PRIMARY MACRONODULAR ADRENAL HYPERPLASIA.
    Suzuki S; Tatsuno I; Oohara E; Nakayama A; Komai E; Shiga A; Kono T; Takiguchi T; Higuchi S; Sakuma I; Nagano H; Hashimoto N; Mayama T; Koide H; Sasano H; Nakatani Y; Imamoto T; Ichikawa T; Yokote K; Tanaka T
    Endocr Pract; 2015 Oct; 21(10):1152-60. PubMed ID: 26214113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Aldosteronism and ARMC5 Variants.
    Zilbermint M; Xekouki P; Faucz FR; Berthon A; Gkourogianni A; Schernthaner-Reiter MH; Batsis M; Sinaii N; Quezado MM; Merino M; Hodes A; Abraham SB; Libé R; Assié G; Espiard S; Drougat L; Ragazzon B; Davis A; Gebreab SY; Neff R; Kebebew E; Bertherat J; Lodish MB; Stratakis CA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E900-9. PubMed ID: 25822102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia.
    Gagliardi L; Schreiber AW; Hahn CN; Feng J; Cranston T; Boon H; Hotu C; Oftedal BE; Cutfield R; Adelson DL; Braund WJ; Gordon RD; Rees DA; Grossman AB; Torpy DJ; Scott HS
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1784-92. PubMed ID: 24905064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.
    Faucz FR; Zilbermint M; Lodish MB; Szarek E; Trivellin G; Sinaii N; Berthon A; Libé R; Assié G; Espiard S; Drougat L; Ragazzon B; Bertherat J; Stratakis CA
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1113-9. PubMed ID: 24601692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
    Yu L; Zhang J; Guo X; Chen X; He Z; He Q
    PLoS One; 2018; 13(1):e0191602. PubMed ID: 29370219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.
    Daniil G; Fernandes-Rosa FL; Chemin J; Blesneac I; Beltrand J; Polak M; Jeunemaitre X; Boulkroun S; Amar L; Strom TM; Lory P; Zennaro MC
    EBioMedicine; 2016 Nov; 13():225-236. PubMed ID: 27729216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.
    Alencar GA; Lerario AM; Nishi MY; Mariani BM; Almeida MQ; Tremblay J; Hamet P; Bourdeau I; Zerbini MC; Pereira MA; Gomes GC; Rocha Mde S; Chambo JL; Lacroix A; Mendonca BB; Fragoso MC
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1501-9. PubMed ID: 24708098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).
    Mulatero P; Tizzani D; Viola A; Bertello C; Monticone S; Mengozzi G; Schiavone D; Williams TA; Einaudi S; La Grotta A; Rabbia F; Veglio F
    Hypertension; 2011 Nov; 58(5):797-803. PubMed ID: 21876069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mother/daughter case of familial hyperaldosteronism.
    Somekh NN; Finkielstein D
    Clin Cardiol; 2010 Dec; 33(12):E68-9. PubMed ID: 20865750
    [No Abstract]   [Full Text] [Related]  

  • 12. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.
    Jeske YW; So A; Kelemen L; Sukor N; Willys C; Bulmer B; Gordon RD; Duffy D; Stowasser M
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):380-5. PubMed ID: 18307725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.
    Carvajal CA; Stehr CB; González PA; Riquelme EM; Montero T; Santos MJ; Kalergis AM; Fardella CE
    J Endocrinol Invest; 2011 Feb; 34(2):140-4. PubMed ID: 20634641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience.
    Pallauf A; Schirpenbach C; Zwermann O; Fischer E; Morak M; Holinski-Feder E; Hofbauer L; Beuschlein F; Reincke M
    Horm Metab Res; 2012 Mar; 44(3):215-20. PubMed ID: 22274719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).
    Lafferty AR; Torpy DJ; Stowasser M; Taymans SE; Lin JP; Huggard P; Gordon RD; Stratakis CA
    J Med Genet; 2000 Nov; 37(11):831-5. PubMed ID: 11073536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
    Albiger NM; Regazzo D; Rubin B; Ferrara AM; Rizzati S; Taschin E; Ceccato F; Arnaldi G; Pecori Giraldi F; Stigliano A; Cerquetti L; Grimaldi F; De Menis E; Boscaro M; Iacobone M; Occhi G; Scaroni C
    Endocrine; 2017 Mar; 55(3):959-968. PubMed ID: 27094308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia.
    Zhang Q; Cui L; Gao JP; Yan WH; Jin N; Chen K; Zang L; Du J; Wang XL; Guo QH; Yang GQ; Yang LJ; Ba JM; Gu WJ; Lv ZH; Dou JT; Mu YM; Lu JM
    Endocr J; 2018 Mar; 65(3):269-279. PubMed ID: 29279458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.
    Okuno Y; Fukuhara A; Otsuki M; Shimomura I
    JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35862218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hyperaldosteronism.
    Stowasser M; Gordon RD
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.